Total Payments
$4,823
2024 Payments
$739.04
Companies
26
Transactions
254
Medicare Patients
1,193
Medicare Billing
$115,182
Payment Breakdown by Category
Food & Beverage$4,823 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,823 | 254 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,091 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,030 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $698.16 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $461.59 | 24 | $0 (2024) |
| PFIZER INC. | $385.96 | 19 | $0 (2022) |
| Gilead Sciences, Inc. | $140.18 | 7 | $0 (2023) |
| Novo Nordisk Inc | $135.53 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $130.10 | 2 | $0 (2024) |
| Becton, Dickinson and Company | $123.73 | 1 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $89.79 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $739.04 | 29 | AstraZeneca Pharmaceuticals LP ($243.58) |
| 2023 | $725.51 | 36 | AstraZeneca Pharmaceuticals LP ($272.53) |
| 2022 | $1,227 | 74 | AstraZeneca Pharmaceuticals LP ($398.10) |
| 2021 | $408.75 | 29 | E.R. Squibb & Sons, L.L.C. ($138.79) |
| 2020 | $347.48 | 20 | E.R. Squibb & Sons, L.L.C. ($135.34) |
| 2019 | $388.82 | 24 | AstraZeneca Pharmaceuticals LP ($86.61) |
| 2018 | $566.69 | 32 | PFIZER INC. ($230.99) |
| 2017 | $419.18 | 10 | E.R. Squibb & Sons, L.L.C. ($244.36) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.75 | General |
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Rare Disease | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $116.39 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Cardiovascular | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Cardiovascular | ||||||
| 03/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 22 | $5,284 | $1,909 |
| 2022 | 5 | 150 | 181 | $34,534 | $14,793 |
| 2021 | 6 | 502 | 626 | $118,997 | $46,499 |
| 2020 | 5 | 525 | 732 | $137,286 | $51,981 |
Total Patients
1,193
Total Services
1,561
Medicare Billing
$115,182
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 22 | $5,284 | $1,909 | 36.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 79 | $16,475 | $7,011 | 42.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 28 | $6,009 | $2,672 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 38 | $5,532 | $2,362 | 42.7% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 21 | 21 | $4,325 | $1,835 | 42.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 15 | 15 | $2,193 | $913.29 | 41.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 164 | 220 | $45,917 | $18,364 | 40.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 117 | 178 | $25,833 | $10,066 | 39.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 108 | 111 | $23,914 | $9,660 | 40.4% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 71 | 72 | $15,064 | $5,797 | 38.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 31 | 31 | $4,519 | $1,646 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 14 | $3,749 | $966.00 | 25.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 170 | 235 | $50,854 | $19,363 | 38.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 150 | 286 | $42,946 | $16,327 | 38.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 93 | 94 | $20,919 | $8,051 | 38.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 70 | 74 | $16,070 | $5,810 | 36.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 42 | 43 | $6,497 | $2,430 | 37.4% |
About Dr. Simona Eng, DO
Dr. Simona Eng, DO is a Internal Medicine healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265431027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simona Eng, DO has received a total of $4,823 in payments from pharmaceutical and medical device companies, with $739.04 received in 2024. These payments were reported across 254 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,823).
As a Medicare-enrolled provider, Eng has provided services to 1,193 Medicare beneficiaries, totaling 1,561 services with total Medicare billing of $115,182. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Salisbury, MD
- Active Since 07/14/2005
- Last Updated 04/24/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265431027
Products in Payments
- ELIQUIS (Drug) $1,162
- XARELTO (Drug) $736.61
- LOKELMA (Drug) $606.18
- ENTRESTO (Drug) $439.21
- FARXIGA (Drug) $355.12
- CAMZYOS (Drug) $160.92
- CHANTIX (Drug) $131.29
- NUCALA (Biological) $130.10
- CFN PleurX (Device) $123.73
- Ozempic (Drug) $101.13
- LifeVest (Device) $89.79
- BRILINTA (Drug) $52.98
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $46.72
- GATTEX (Drug) $44.72
- Veltassa (Drug) $39.79
- REBYOTA (Biological) $36.38
- Rybelsus (Drug) $34.40
- Repatha (Biological) $31.81
- Inpefa (Drug) $29.03
- BEVYXXA (Drug) $26.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salisbury
Akhil Parashar, M.d, M.D
Internal Medicine — Payments: $48,967
Internal Medicine $48,967
Stacy Kennedy, M.d, M.D
Internal Medicine — Payments: $26,914
Internal Medicine $26,914
Dr. Robert Mcneill, M.d, M.D
Internal Medicine — Payments: $14,247
Internal Medicine $14,247
Karim Arnaout, M.d, M.D
Internal Medicine — Payments: $8,657
Internal Medicine $8,657
Dr. David Bearss, M.d, M.D
Internal Medicine — Payments: $7,098
Internal Medicine $7,098
Dr. Justin Kucinski, Do, DO
Internal Medicine — Payments: $7,018
Internal Medicine $7,018